Add BrightSurf on Google Email

More than 1.15 million fertility treatment cycles reported across Europe and the impact of frozen embryo transfer continues to grow

According to the European IVF Monitoring Consortium, over 1.15 million fertility treatment cycles were reported across Europe in 2023, resulting in the birth of 247,021 children. The growth in frozen embryo transfer (FET) was particularly notable, with FET cycles increasing by 151% compared to previous years.

IVF not linked to higher overall cancer rates, but study shows differences in some cancers

A large Australian study of over 417,000 women found that fertility treatments were not linked to higher overall cancer rates, but some cancers were slightly more common, while others were less common. Women who received fertility treatment were more likely to develop uterine and ovarian cancer, as well as melanoma, but the overall ris...

SourceUniversity of New South Wales·JournalJAMA Network Open·TypeObservational study·DateMar 11, 2026

Researchers ‘listen in’ to embryo-mother interactions during implantation using a culture system replicating the womb lining

Scientists have engineered a system replicating the womb lining to investigate embryo-mother interactions during implantation. The new model reveals crucial details about the complex communication between the embryo and endometrium, shedding light on causes of implantation failure and pregnancy complications.

SourceBabraham Institute·JournalCell·TypeExperimental study·DateDec 23, 2025

Stowers scientists identify the fusion point of Robertsonian chromosomes, hinting at how chromosomes evolve

Researchers at Stowers Institute for Medical Research have identified the precise location where human chromosomes break and recombine to form Robertsonian chromosomes. The study reveals that repetitive DNA sequences play a central role in genome organization and evolution, explaining how these rearrangements form and remain stable.

SourceStowers Institute for Medical Research·JournalNature·TypeExperimental study·DateSep 24, 2025

Older paternal age linked to higher miscarriage risk and lower live birth rates in donor egg IVF cycles, new study finds

A new international study reveals that male partners over 45 carry significantly increased miscarriage risks and lower live birth rates even when young donor eggs are used. The study found that older paternal age is linked to genetic mutations, sperm DNA fragmentation, and epigenetic changes, impairing embryo development.

Researchers create ‘super stem cells’, seeing potential for improved fertility treatment

Scientists at the University of Copenhagen have created 'super stem cells' that outperform regular stem cells by developing into multiple cell types. These 'super stem cells' show promise in improving fertility treatment, particularly IVF success rates, by producing essential tissue for early embryonic development.

Boosting immune cell tolerance may help prevent early pregnancy loss

A new study suggests that boosting T-regulatory cells may improve the chance of healthy pregnancy and reduce miscarriage risk. Researchers found that treatment with interleukin-2 and antibodies targeting these cells improved pregnancy outcomes in mice, reducing miscarriage rates from 30% to 11%.

SourceElsevier·JournalAmerican Journal Of Pathology·TypeExperimental study·DateOct 29, 2024

Time-lapse imaging for embryo selection in IVF does not improve the odds of live birth compared with conventional methods, according to largest study of its kind

A large-scale randomized controlled trial found no difference in live birth rates between time-lapse imaging and standard approaches used in IVF. The study suggests that time-lapse imaging does not improve clinical outcomes for women undergoing fertility treatment, contrary to theoretical benefits.

SourceQueen Mary University of London·JournalThe Lancet·TypeRandomized controlled/clinical trial·DateJul 18, 2024

Gestational carriers face higher health risks during pregnancy compared to IVF and natural conceptions, new study shows

A new study has found that gestational carriers experience a severe maternal morbidity rate of 7.1%, significantly higher than unassisted conceptions (2.4%) and IVF conceptions (4.6%). Gestational carriers are also at risk for postpartum haemorrhages and hypertensive disorders, which can be serious complications during pregnancy.

Public acceptance of adoption and surrogacy methods currently prohibited in UK increases if one or both parents are infertile - study

A new study from the University of Birmingham and the University of Nottingham found that the UK public is more accepting of adoption and surrogacy methods when one or both parents are infertile. The research showed significant increases in support for these methods, including planned private adoption and double donor surrogacy.

SourceUniversity of Birmingham·JournalJournal of Bioethical Inquiry·TypeSurvey·DateJun 13, 2024

Assisted reproductive technologies not associated with body mass index in children, except when using frozen embryos – according to new Danish study

A new study published in PLOS Medicine found no association between assisted reproductive technologies and body mass index in children, except when using frozen embryos. The study analyzed data from Denmark and other countries, providing insights into the health outcomes of children born through assisted reproductive technologies.

SourcePLOS·JournalPLOS Medicine·DateDec 19, 2023

Pro-viral human protein critical for embryo development

Researchers discovered that ZC3H11A is essential for regulating metabolic genes in embryos and their absence leads to complete lethality. The study's findings suggest that ZC3 may be a promising therapeutic target for the development of anti-viral agents against medically significant human viruses.

SourceUppsala University·JournalProceedings of the National Academy of Sciences·TypeExperimental study·DateMay 31, 2023

The beginning of life: The early embryo is in the driver's seat

Researchers using 'blastoids' - in vitro models of the blastocyst - discovered that early embryonic signals induce placental development and prepare the uterus. The findings may contribute to a better understanding of human fertility and potentially improve IVF procedures, fertility drugs, and contraceptives.

Frozen embryo transfers in IVF linked to greater risk of maternal hypertension in pregnancy

A large study analyzing over 4.5 million pregnancies found that frozen embryo transfers in IVF are associated with a substantially higher risk of hypertensive disorders, particularly pre-eclampsia, compared to naturally conceived pregnancies. The risk was roughly doubled for FETs, while fresh embryo transfers had similar outcomes.

In world-first, Tel Aviv University researchers engineer human spinal cord implants for treating paralysis

Researchers from Tel Aviv University have engineered 3D human spinal cord tissues and implanted them in lab models with long-term chronic paralysis, resulting in an 80% success rate in restoring walking abilities. The team aims to conduct clinical trials in human patients within a few years to make the treatment commercially available.

SourceTel-Aviv University·JournalAdvanced Science·DateFeb 7, 2022

Breakthrough research on human embryo models paves the way for improving in vitro fertilization success rate and new non-hormonal, user-friendly contraception

Researchers have discovered molecules that could be candidates for contraceptives or fertility enhancers using human blastoid models. These models also show promise in improving the self-organization of stem cells during IVF procedures.

New evidence identified on safety of IVF embryo screening method

Researchers at the University of Kent identified strong evidence-based benefits of preimplantation genetic testing for aneuploidy (PGT-A) in IVF. Live birth rates per embryo transferred and per treatment cycle were significantly higher with PGT-A compared to regular IVF, especially in women over 40.

SourceUniversity of Kent·JournalJournal of Assisted Reproduction and Genetics·TypeObservational study·DateNov 15, 2021

Choosing the 'best' embryo in IVF

Researchers found that selecting the embryo with the lowest predicted risk score reduces disease risk more effectively than eliminating high-scoring embryos. However, polygenic embryo screening offers no guarantees about a baby's health and has limited effectiveness depending on factors like ancestry and age.

SourceThe Hebrew University of Jerusalem·JournaleLife·TypeData/statistical analysis·DateOct 12, 2021

New discovery pinpoints the ‘golden window’ for IVF success

Researchers at RMIT University have discovered a Teflon-like molecule on the womb's surface that decreases at a certain point in the menstrual cycle, opening the 'golden window' for pregnancy success. This finding could lead to improved IVF success rates and potentially treat underlying causes of infertility.

SourceRMIT University·JournalFertility and Sterility·TypeExperimental study·DateAug 23, 2021